Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara I Pai

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Oral Oncology|May 7, 2013
Mission impossible: how HPV-associated head and neck cancers escape a primed immune responseSara I Pai
Otolaryngologic Clinics of North America|July 17, 2012
HPV-associated head and neck cancersSara I Pai
Oncoimmunology|June 14, 2013
Adaptive immune resistance in HPV-associated head and neck squamous cell carcinomaSara I Pai
Otolaryngologic Clinics of North America|June 24, 2008
The molecular genetics of laryngeal cancerMyriam Loyo, Sara I Pai
Annual Review of Pathology|August 30, 2008
Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatmentSara I Pai, William H Westra
Otolaryngologic Clinics of North America|June 1, 2010
Reoperation for recurrent/persistent well-differentiated thyroid cancerSara I Pai, Ralph P Tufano
Trends in Cancer|January 19, 2020
Peripheral Circulating CD45RA<sup>-</sup>FOXP3<sup>hi</sup> T Regulatory (T<sub>R</sub><sub>eg</sub>) II Cells Provide a Window into the Activity of Intratumoral T<sub>R</sub><sub>eg</sub> CellsSara I Pai, Francesco M Marincola
Emerging Topics in Life Sciences|February 2, 2021
Checkpoint cluster: biomarkers of responseSara I Pai, Lori J Wirth
Cancer Cytopathology|May 5, 2017
Programmed cell death ligand 1 as a biomarker in head and neck cancerSara I Pai, William C Faquin
Cancer Journal (Sudbury, Mass.)|September 27, 2022
Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal CancerJean S Campbell, Sara I Pai
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Oral Oncology|May 7, 2013
Mission impossible: how HPV-associated head and neck cancers escape a primed immune responseSara I Pai
Otolaryngologic Clinics of North America|July 17, 2012
HPV-associated head and neck cancersSara I Pai
Oncoimmunology|June 14, 2013
Adaptive immune resistance in HPV-associated head and neck squamous cell carcinomaSara I Pai
Otolaryngologic Clinics of North America|June 24, 2008
The molecular genetics of laryngeal cancerMyriam Loyo, Sara I Pai
Annual Review of Pathology|August 30, 2008
Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatmentSara I Pai, William H Westra
Otolaryngologic Clinics of North America|June 1, 2010
Reoperation for recurrent/persistent well-differentiated thyroid cancerSara I Pai, Ralph P Tufano
Trends in Cancer|January 19, 2020
Peripheral Circulating CD45RA<sup>-</sup>FOXP3<sup>hi</sup> T Regulatory (T<sub>R</sub><sub>eg</sub>) II Cells Provide a Window into the Activity of Intratumoral T<sub>R</sub><sub>eg</sub> CellsSara I Pai, Francesco M Marincola
Emerging Topics in Life Sciences|February 2, 2021
Checkpoint cluster: biomarkers of responseSara I Pai, Lori J Wirth
Cancer Cytopathology|May 5, 2017
Programmed cell death ligand 1 as a biomarker in head and neck cancerSara I Pai, William C Faquin
Cancer Journal (Sudbury, Mass.)|September 27, 2022
Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal CancerJean S Campbell, Sara I Pai
Pageof 12